Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009;11(3):228.
doi: 10.1186/ar2656. Epub 2009 May 19.

Developments in the scientific understanding of osteoporosis

Nancy E Lane  1 , Wei Yao
Affiliations
Review

Developments in the scientific understanding of osteoporosis

Nancy E Lane et al. Arthritis Res Ther. 2009.

Abstract

During the past 10 years we have experienced very significant developments in our understanding of bone biology, and this has improved our abilities to both diagnose and treat patients with osteoporosis. This review covers some of the significant discoveries in bone biology that have led to a better understanding of osteoporosis, including a few of the discoveries that have been translated into new therapies to treat patients with osteoporosis and the structural deterioration of patients with inflammatory arthritis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pathways for osteogenesis and osteoclastogenesis. Osteoblasts mature from mesenchymal stem cells to preosteoblasts. The Wnt signaling pathway antagonists (DKK-1, sclerostin, and SFRP1) and serotonin all inhibit osteogenesis. A number of cell types can synthesize Wnt signaling antagonists. Fibroblast-like synoviocytes from rheumatoid arthritis patients after stimulation with TNF-α, and myeloma cells synthesize DKK-1 and osteocytes synthesize sclerostin. Osteoblasts also now are known to be the main controllers of osteoclastogenesis through the production of RANKL by pre-osteoblast cells. The antagonist of RANKL, OPG, is produced by mature osteoblasts and prevents RANKL from binding to its receptor, RANK, so that osteoclast maturation and activity are inhibited. DKK, dickkopf; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand; SFRP, secreted frizzled-related protein; TNF, tumor necrosis factor.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Datta HK, Ng WF, Walker JA, Tuck SP, Varanasi SS. The cell biology of bone metabolism. J Clin Pathol. 2008;61:577–587. doi: 10.1136/jcp.2007.048868. - DOI - PubMed
    1. Sims NA, Gooi JH. Bone remodeling: multiple cellular interactions required for coupling of bone formation and resorption. Semin Cell Dev Biol. 2008;19:444–451. doi: 10.1016/j.semcdb.2008.07.016. - DOI - PubMed
    1. Lips P, Courpron P, Meunier PJ. Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif Tissue Res. 1978;26:13–17. doi: 10.1007/BF02013227. - DOI - PubMed
    1. Gillespie MT. Impact of cytokines and T lymphocytes upon osteoclast differentiation and function. Arthritis Res Ther. 2007;9:103. doi: 10.1186/ar2141. - DOI - PMC - PubMed
    1. Horowitz MC, Lorenzo JA. B lymphocytes and the skeleton. Ann N Y Acad Sci. 2007;1117:82–93. doi: 10.1196/annals.1402.045. - DOI - PubMed

Publication types